The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 03, 2015

Filed:

Aug. 26, 2009
Applicants:

Jean-luc Georges Laurent Battini, Montpellier, FR;

Nicolas Gabriel Albert Manel, Montpellier, FR;

Felix Jinhyun Kim, San Diego, CA (US);

Sandrina Kinet, Montarnaud, FR;

Naomi Taylor, Montpellier, FR;

Marc Sitbon, Montpellier, FR;

Inventors:

Jean-Luc Georges Laurent Battini, Montpellier, FR;

Nicolas Gabriel Albert Manel, Montpellier, FR;

Felix Jinhyun Kim, San Diego, CA (US);

Sandrina Kinet, Montarnaud, FR;

Naomi Taylor, Montpellier, FR;

Marc Sitbon, Montpellier, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/16 (2006.01); A61P 35/00 (2006.01); A61P 37/06 (2006.01); G01N 33/566 (2006.01); C07K 14/005 (2006.01); C07K 14/62 (2006.01); C07K 14/705 (2006.01);
U.S. Cl.
CPC ...
G01N 33/566 (2013.01); A61K 38/162 (2013.01); C07K 14/005 (2013.01); C07K 14/62 (2013.01); C07K 14/705 (2013.01); C12N 2740/15022 (2013.01); C12N 2740/15045 (2013.01); C12N 2810/6054 (2013.01);
Abstract

The invention relates to the use of the ubiquitous vertebrate glucose transporter GLUT1, or of fragments or sequences derived thereof, for the in vitro diagnosis of cancers, when used as a tumor marker, or for the screening of compounds useful for the preparation of drugs for the prevention or the treatment of pathologies linked to an infection of an individual with a PTLV, or pathologies linked to an overexpression of GLUT1 on cell surfaces, or the in vitro detection of GLUT1 on cell surfaces. The invention also relates to pharmaceutical compositions containing GLUT1, or fragments or sequences derived thereof, and to their uses such as in the frame of the prevention or the treatment of pathologies linked to an infection of an individual with a PTLV.


Find Patent Forward Citations

Loading…